检索结果 - Hiromitsu Kumada
- Showing 1 - 20 results of 68
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study 由 Ryosuke Tateishi, Takeshi Okanoue, Naoto Fujiwara, Kiwamu Okita, Kendo Kiyosawa, Masao Omata, Hiromitsu Kumada, Norio Hayashi, Kazuhiko Koike
出版 2014Artigo -
9
-
10
Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis 由 Masahiro Kobayashi, Kenji Ikeda, Satoshi Saitoh, Fumitaka Suzuki, Akihito Tsubota, Yoshiyuki Suzuki, Yasuji Arase, N Murashima, Kazuaki Chayama, Hiromitsu Kumada
出版 2000Artigo -
11
Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor—A prospective randomized study of hepatitis C virus–relate... 由 Kenji Ikeda, Yasuji Arase, Satoshi Saitoh, Masahiro Kobayashi, Yoshiyuki Suzuki, Fumitaka Suzuki, Akihito Tsubota, Kazuaki Chayama, Naoya Murashima, Hiromitsu Kumada
出版 2000Artigo -
12
Randomized trial of interferon‐ and ribavirin‐free ombitasvir/paritaprevir/ritonavir in treatment‐experienced hepatitis C virus–infected patients 由 Kazuaki Chayama, Kazuo Notsumata, Masayuki Kurosaki, Ken Sato, Lino Rodrigues, Carolyn M. Setze, Prajakta Badri, Edward Tam, Regis A. Vilchez, Hiromitsu Kumada
出版 2015Artigo -
13
Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2795 patients 由 Akihiro Matsumoto, Eiji Tanaka, Akinori Rokuhara, Kendo Kiyosawa, Hiromitsu Kumada, Masao Omata, Kiwamu Okita, Norio Hayashi, Takeshi Okanoue, Shiro Iino, Kyuichi Tanikawa
出版 2005Artigo -
14
Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis 由 Masahiro Kobayashi, Kenji Ikeda, Tetsuya Hosaka, Hitomi Sezaki, Takashi Someya, Norio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, Satoshi Saitoh, Yasuji Arase, Hiromitsu Kumada
出版 2005Artigo -
15
ITPA Polymorphism Affects Ribavirin-Induced Anemia and Outcomes of Therapy—A Genome-Wide Study of Japanese HCV Virus Patients 由 Hidenori Ochi, T Maekawa, Hiromi Abe, Yasufumi Hayashida, Rikita Nakano, Michaki Kubo, Tatsuhiko Tsunoda, C. Nelson Hayes, Hiromitsu Kumada, Yusuke Nakamura, Kazuaki Chayama
出版 2010Artigo -
16
Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus 由 Kenji Ikeda, Satoshi Saitoh, Yoshiyuki Suzuki, Masahiro Kobayashi, Akihito Tsubota, Mizuho Fukuda, Isao Koida, Yasuji Arase, Kazuaki Chayama, N Murashima, Hiromitsu Kumada
出版 1998Artigo -
17
High serum des‐gamma‐carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma 由 Masahiro Kobayashi, Kenji Ikeda, Yusuke Kawamura, Hiromi Yatsuji, Tetsuya Hosaka, Hitomi Sezaki, Norio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, Satoshi Saitoh, Yasuji Arase, Hiromitsu Kumada
出版 2009Artigo -
18
Effect of Interferon Therapy on Hepatocellular Carcinogenesis in Patients With Chronic Hepatitis Type C: A Long–Term Observation Study of 1,643 Patients Using Statistical Bias Corr... 由 Kenji Ikeda, Satoshi Saitoh, Yasuji Arase, Kazuaki Chayama, Yoshiyuki Suzuki, Masahiro Kobayashi, Akihito Tsubota, Mizuho Kobayashi, Ikuo Nakamura, Naoya Murashima, Hiromitsu Kumada, Masahiro Kawanishi
出版 1999Artigo -
19
-
20
Long-Term Outcome after Hepatitis B Surface Antigen Seroclearance in Patients with Chronic Hepatitis B 由 Yasuji Arase, Kenji Ikeda, Fumitaka Suzuki, Yoshiyuki Suzuki, Satoshi Saitoh, Masahiro Kobayashi, Norio Akuta, Takashi Someya, Tetsuya Hosaka, Hitomi Sezaki, Mariko Kobayashi, Hiromitsu Kumada
出版 2006Artigo
相关主题
Medicine
Internal medicine
Gastroenterology
Hepatocellular carcinoma
Virus
Biology
Hepatitis C virus
Immunology
Cirrhosis
Virology
Gene
Oncology
Ribavirin
Genetics
Hepatitis C
Confidence interval
Hepatology
Hazard ratio
Hepatitis B virus
Pathology
Physics
Genotype
Adverse effect
Cancer research
Hepatitis B
Incidence (geometry)
Lenvatinib
Optics
Proportional hazards model
Sorafenib